Variant report
Variant | esv2752270 |
---|---|
Chromosome Location | chr8:96450447-96459194 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3133757 | chr8:96451633-96451634 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs3104910 | chr8:96451654-96451655 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs35537230 | chr8:96451666-96451667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529936313 | chr8:96451669-96451670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550091145 | chr8:96451680-96451681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146372143 | chr8:96451701-96451702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs3133758 | chr8:96451717-96451718 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs558287706 | chr8:96451722-96451723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565744297 | chr8:96451740-96451741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534521793 | chr8:96453820-96453821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570537841 | chr8:96453832-96453833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533305264 | chr8:96453894-96453895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191168169 | chr8:96453899-96453900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566787049 | chr8:96453903-96453904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535776925 | chr8:96454121-96454122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555317497 | chr8:96454129-96454130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554705663 | chr8:96454320-96454321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139938316 | chr8:96454359-96454360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9297958 | chr8:96454382-96454383 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs10088272 | chr8:96454385-96454386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201450481 | chr8:96454434-96454435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs578050813 | chr8:96454453-96454454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9297959 | chr8:96454506-96454507 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs144878483 | chr8:96454532-96454533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573152963 | chr8:96454550-96454551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs73697805 | chr8:96454564-96454565 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs367969616 | chr8:96454574-96454575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373337892 | chr8:96454583-96454584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376460227 | chr8:96454584-96454585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113784999 | chr8:96454657-96454658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530388645 | chr8:96454729-96454730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs182957198 | chr8:96454740-96454741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7001207 | chr8:96454743-96454744 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
34 | rs532877367 | chr8:96454779-96454780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145856138 | chr8:96454786-96454787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577289711 | chr8:96454828-96454829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529539228 | chr8:96454834-96454835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs186604854 | chr8:96454839-96454840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10105331 | chr8:96454849-96454850 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs554772083 | chr8:96454883-96454884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551768639 | chr8:96454888-96454889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34419718 | chr8:96454908-96454909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546192555 | chr8:96454924-96454925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192558514 | chr8:96455003-96455004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559901723 | chr8:96455016-96455017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534318675 | chr8:96455017-96455018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147835026 | chr8:96455021-96455022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs573118083 | chr8:96455031-96455032 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs569778311 | chr8:96455048-96455049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs3133763 | chr8:96455051-96455052 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
head and neck squamous cell carcinoma | 19451471 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Mental retardation | 17847001 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Breast cancer | 21611746 | CNVD |
Breast cancer | 17142309 | CNVD |
Malignant melanoma | 17260012 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:96451600-96451800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr8:96453800-96454800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr8:96453800-96455400 | Enhancers | HUVEC | blood vessel |
4 | chr8:96454200-96454800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr8:96454200-96454800 | Enhancers | Osteobl | bone |
6 | chr8:96454400-96454800 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr8:96454800-96456200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr8:96455000-96456000 | Enhancers | Right Ventricle | heart |
9 | chr8:96455800-96456800 | Enhancers | Fetal Heart | heart |
10 | chr8:96456200-96456400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |